Literature DB >> 22972990

Toward an efficient and integrative analysis of limited-choice behavioral experiments.

Karl Schilling1, John Oberdick, René L Schilling.   

Abstract

Mesh：

Year:  2012        PMID： 22972990      PMCID： PMC6703800          DOI： 10.1523/JNEUROSCI.1452-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN： 0270-6474            Impact factor:   6.167


× No keyword cloud information.
  6 in total

Review 1.  Choosiness, a neglected aspect of preference functions: a review of methods, challenges and statistical approaches.

Authors:  Klaus Reinhold; Holger Schielzeth
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2014-11-15       Impact factor: 1.836

2.  Ventromedial frontal lobe damage affects interpretation, not exploration, of emotional facial expressions.

Authors:  Avinash R Vaidya; Lesley K Fellows
Journal:  Cortex       Date:  2019-01-14       Impact factor: 4.027

3.  Preferential Delivery of an Opioid Antagonist to the Fetal Brain in Pregnant Mice.

Authors:  John Oberdick; Yonghua Ling; Mitch A Phelps; Max S Yudovich; Karl Schilling; Wolfgang Sadee
Journal:  J Pharmacol Exp Ther       Date:  2016-05-05       Impact factor: 4.030

4.  Multi-channel acoustic recording and automated analysis of Drosophila courtship songs.

Authors:  Benjamin J Arthur; Tomoko Sunayama-Morita; Philip Coen; Mala Murthy; David L Stern
Journal:  BMC Biol       Date:  2013-01-31       Impact factor: 7.431

5.  Predicting addictive vulnerability: individual differences in initial responding to a drug's pharmacological effects.

Authors:  Douglas S Ramsay; Salwa Al-Noori; Jason Shao; Brian G Leroux; Stephen C Woods; Karl J Kaiyala
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

6.  The µ-opioid system in midline thalamic nuclei modulates defence strategies towards a conditioned fear stimulus in male mice.

Authors:  Xabier Bengoetxea; Lena Goedecke; Peter Blaesse; Hans-Christian Pape; Kay Jüngling
Journal:  J Psychopharmacol       Date:  2020-07-20       Impact factor: 4.153
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.